The Future of Bullous Pemphigoid (BP): New and Promising Drugs May Revolutionize Treatment Course for BP Patients

Abstract

Keywords

bullous pemphigoid rituximab steroids

Get full access to this article

View all access options for this article.

References

Polansky

Eisenstadt

DeGrazia

Zhao

Liu

Feldman

. Rituximab therapy in patients with bullous pemphigoid: a retrospective study of 20 patients. J Am Acad Dermatol. 2019;81(1):179-186.doi:10.1016/j.jaad.2019.03.049

Fudge

JG.

Crawford

. Bullous pemphigoid: a 10-year study of discordant results on direct immunofluorescence. J Cutan Med Surg. 2018;22(5):472-475.doi:10.1177/1203475418773359

Miyamoto

Santi

CG.

Aoki

Maruta

CW.

pemphigoid

. Bullous pemphigoid. An Bras Dermatol. 2019;94(2):133-146.doi:10.1590/abd1806-4841.20199007

Lee

SG.

Lee

HJ.

Yoon

MS.

Kim

. Association of dipeptidyl peptidase 4 inhibitor use with risk of bullous pemphigoid in patients with diabetes. JAMA Dermatol. 2019;155(2):172-177.doi:10.1001/jamadermatol.2018.4556

Lamberts

Meijer

JM.

Pas

HH.

Diercks

GFH.

Horváth

Jonkman

. Nonbullous pemphigoid: insights in clinical and diagnostic findings, treatment responses, and prognosis. J Am Acad Dermatol. 2019;81(2):355-363.doi:10.1016/j.jaad.2019.04.029

Kirtschig

Middleton

Bennett

Murrell

DF.

Wojnarowska

Khumalo

. Interventions for bullous pemphigoid. Cochrane Database Syst Rev. 2010;10:CD002292.

Mikulska

Lanini

Gudiol

et al. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52). Clin Microbiol Infect. 2018;24(Suppl 2):S71-S82.doi:10.1016/j.cmi.2018.02.003

Kremer

Snast

Cohen

et al. Rituximab and omalizumab for the treatment of bullous pemphigoid: a systematic review of the literature. Am J Clin Dermatol. 2019;20(2):209-216.doi:10.1007/s40257-018-0401-6

Izumi

Bieber

Ludwig

. Current clinical trials in pemphigus and pemphigoid. Front Immunol. 2019;10:978.doi:10.3389/fimmu.2019.00978